Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting
Background The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action...
Gespeichert in:
Veröffentlicht in: | The Prostate 2016-02, Vol.76 (2), p.125-139 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 139 |
---|---|
container_issue | 2 |
container_start_page | 125 |
container_title | The Prostate |
container_volume | 76 |
creator | Miyahira, Andrea K. Lang, Joshua M. Den, Robert B. Garraway, Isla P. Lotan, Tamara L. Ross, Ashley E. Stoyanova, Tanya Cho, Steve Y. Simons, Jonathan W. Pienta, Kenneth J. Soule, Howard R. |
description | Background
The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015.
Methods
The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action‐tank‐structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure.
Results
The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high‐risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi‐modal care of high risk and oligometastatic patients.
Discussion
This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high‐risk and oligometastatic prostate cancer patients. Prostate 76:125–139, 2016. © 2015 Wiley Periodicals, Inc. |
doi_str_mv | 10.1002/pros.23107 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5830186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3923841411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5217-c44f4666803e02800ce860310b02754d5201ef0ebde3187fe17b9309b5f6bd303</originalsourceid><addsrcrecordid>eNpVUc1u1DAQthCILi0XHgBZ4krKOI7jhANStUCL1NJVAYF6sZxk0nVJ7OB4C3mJPnO9u-2qnGak-X5mviHkFYNDBpC-G7wbD1POQD4hMwalTAAy8ZTMIJWQZIzLPfJiHK8BIhzS52QvzTMpcyhn5PZs1QXTmLE2Q2es9hM1NqC_QRuMs9S1FLXvpre0w7DUHe0x6DHoYGq69o0d0lrbGv17eoGD84G23vU0LJGmwASdu7bFKTlxXYOWLh448w2HHtW6wX6iZ4jB2KsD8qzV3Ygv7-s--fH50_f5SXJ6fvxlfnSa1CJlMqmzrM3yPC-AI6QFQI1FDjGBKp4sskZEZ2wBqwY5K2SLTFYlh7ISbV41HPg--bDVHVZVj00dr_W6U4M3fYxAOW3U_xNrlurK3ShRcGBFHgXe3At492eFY1DXbuVt3FkxKaQoS1aubV4_ttnpP-QfAWwL-Gs6nHZzBmr9WbVOWG0-qxYX5982XeQkW44ZA_7bcbT_rXLJpVA_vx6rX5cfhbzkC1XwOxgJp6o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1757599190</pqid></control><display><type>article</type><title>Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Miyahira, Andrea K. ; Lang, Joshua M. ; Den, Robert B. ; Garraway, Isla P. ; Lotan, Tamara L. ; Ross, Ashley E. ; Stoyanova, Tanya ; Cho, Steve Y. ; Simons, Jonathan W. ; Pienta, Kenneth J. ; Soule, Howard R.</creator><creatorcontrib>Miyahira, Andrea K. ; Lang, Joshua M. ; Den, Robert B. ; Garraway, Isla P. ; Lotan, Tamara L. ; Ross, Ashley E. ; Stoyanova, Tanya ; Cho, Steve Y. ; Simons, Jonathan W. ; Pienta, Kenneth J. ; Soule, Howard R.</creatorcontrib><description>Background
The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015.
Methods
The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action‐tank‐structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure.
Results
The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high‐risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi‐modal care of high risk and oligometastatic patients.
Discussion
This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high‐risk and oligometastatic prostate cancer patients. Prostate 76:125–139, 2016. © 2015 Wiley Periodicals, Inc.</description><identifier>ISSN: 0270-4137</identifier><identifier>EISSN: 1097-0045</identifier><identifier>DOI: 10.1002/pros.23107</identifier><identifier>PMID: 26477609</identifier><identifier>CODEN: PRSTDS</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Academies and Institutes - trends ; biomarkers ; California ; Congresses as Topic - trends ; diagnosis ; Early Medical Intervention - methods ; Early Medical Intervention - trends ; Humans ; Interprofessional Relations ; Male ; molecular imaging ; oligometastatic ; Patient Care Team - trends ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - therapy ; Research Report ; therapeutics</subject><ispartof>The Prostate, 2016-02, Vol.76 (2), p.125-139</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><rights>2016 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5217-c44f4666803e02800ce860310b02754d5201ef0ebde3187fe17b9309b5f6bd303</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpros.23107$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpros.23107$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26477609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miyahira, Andrea K.</creatorcontrib><creatorcontrib>Lang, Joshua M.</creatorcontrib><creatorcontrib>Den, Robert B.</creatorcontrib><creatorcontrib>Garraway, Isla P.</creatorcontrib><creatorcontrib>Lotan, Tamara L.</creatorcontrib><creatorcontrib>Ross, Ashley E.</creatorcontrib><creatorcontrib>Stoyanova, Tanya</creatorcontrib><creatorcontrib>Cho, Steve Y.</creatorcontrib><creatorcontrib>Simons, Jonathan W.</creatorcontrib><creatorcontrib>Pienta, Kenneth J.</creatorcontrib><creatorcontrib>Soule, Howard R.</creatorcontrib><title>Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting</title><title>The Prostate</title><addtitle>Prostate</addtitle><description>Background
The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015.
Methods
The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action‐tank‐structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure.
Results
The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high‐risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi‐modal care of high risk and oligometastatic patients.
Discussion
This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high‐risk and oligometastatic prostate cancer patients. Prostate 76:125–139, 2016. © 2015 Wiley Periodicals, Inc.</description><subject>Academies and Institutes - trends</subject><subject>biomarkers</subject><subject>California</subject><subject>Congresses as Topic - trends</subject><subject>diagnosis</subject><subject>Early Medical Intervention - methods</subject><subject>Early Medical Intervention - trends</subject><subject>Humans</subject><subject>Interprofessional Relations</subject><subject>Male</subject><subject>molecular imaging</subject><subject>oligometastatic</subject><subject>Patient Care Team - trends</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Research Report</subject><subject>therapeutics</subject><issn>0270-4137</issn><issn>1097-0045</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUc1u1DAQthCILi0XHgBZ4krKOI7jhANStUCL1NJVAYF6sZxk0nVJ7OB4C3mJPnO9u-2qnGak-X5mviHkFYNDBpC-G7wbD1POQD4hMwalTAAy8ZTMIJWQZIzLPfJiHK8BIhzS52QvzTMpcyhn5PZs1QXTmLE2Q2es9hM1NqC_QRuMs9S1FLXvpre0w7DUHe0x6DHoYGq69o0d0lrbGv17eoGD84G23vU0LJGmwASdu7bFKTlxXYOWLh448w2HHtW6wX6iZ4jB2KsD8qzV3Ygv7-s--fH50_f5SXJ6fvxlfnSa1CJlMqmzrM3yPC-AI6QFQI1FDjGBKp4sskZEZ2wBqwY5K2SLTFYlh7ISbV41HPg--bDVHVZVj00dr_W6U4M3fYxAOW3U_xNrlurK3ShRcGBFHgXe3At492eFY1DXbuVt3FkxKaQoS1aubV4_ttnpP-QfAWwL-Gs6nHZzBmr9WbVOWG0-qxYX5982XeQkW44ZA_7bcbT_rXLJpVA_vx6rX5cfhbzkC1XwOxgJp6o</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Miyahira, Andrea K.</creator><creator>Lang, Joshua M.</creator><creator>Den, Robert B.</creator><creator>Garraway, Isla P.</creator><creator>Lotan, Tamara L.</creator><creator>Ross, Ashley E.</creator><creator>Stoyanova, Tanya</creator><creator>Cho, Steve Y.</creator><creator>Simons, Jonathan W.</creator><creator>Pienta, Kenneth J.</creator><creator>Soule, Howard R.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20160201</creationdate><title>Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting</title><author>Miyahira, Andrea K. ; Lang, Joshua M. ; Den, Robert B. ; Garraway, Isla P. ; Lotan, Tamara L. ; Ross, Ashley E. ; Stoyanova, Tanya ; Cho, Steve Y. ; Simons, Jonathan W. ; Pienta, Kenneth J. ; Soule, Howard R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5217-c44f4666803e02800ce860310b02754d5201ef0ebde3187fe17b9309b5f6bd303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Academies and Institutes - trends</topic><topic>biomarkers</topic><topic>California</topic><topic>Congresses as Topic - trends</topic><topic>diagnosis</topic><topic>Early Medical Intervention - methods</topic><topic>Early Medical Intervention - trends</topic><topic>Humans</topic><topic>Interprofessional Relations</topic><topic>Male</topic><topic>molecular imaging</topic><topic>oligometastatic</topic><topic>Patient Care Team - trends</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Research Report</topic><topic>therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miyahira, Andrea K.</creatorcontrib><creatorcontrib>Lang, Joshua M.</creatorcontrib><creatorcontrib>Den, Robert B.</creatorcontrib><creatorcontrib>Garraway, Isla P.</creatorcontrib><creatorcontrib>Lotan, Tamara L.</creatorcontrib><creatorcontrib>Ross, Ashley E.</creatorcontrib><creatorcontrib>Stoyanova, Tanya</creatorcontrib><creatorcontrib>Cho, Steve Y.</creatorcontrib><creatorcontrib>Simons, Jonathan W.</creatorcontrib><creatorcontrib>Pienta, Kenneth J.</creatorcontrib><creatorcontrib>Soule, Howard R.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Prostate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miyahira, Andrea K.</au><au>Lang, Joshua M.</au><au>Den, Robert B.</au><au>Garraway, Isla P.</au><au>Lotan, Tamara L.</au><au>Ross, Ashley E.</au><au>Stoyanova, Tanya</au><au>Cho, Steve Y.</au><au>Simons, Jonathan W.</au><au>Pienta, Kenneth J.</au><au>Soule, Howard R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting</atitle><jtitle>The Prostate</jtitle><addtitle>Prostate</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>76</volume><issue>2</issue><spage>125</spage><epage>139</epage><pages>125-139</pages><issn>0270-4137</issn><eissn>1097-0045</eissn><coden>PRSTDS</coden><abstract>Background
The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015.
Methods
The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action‐tank‐structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure.
Results
The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high‐risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi‐modal care of high risk and oligometastatic patients.
Discussion
This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high‐risk and oligometastatic prostate cancer patients. Prostate 76:125–139, 2016. © 2015 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>26477609</pmid><doi>10.1002/pros.23107</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-4137 |
ispartof | The Prostate, 2016-02, Vol.76 (2), p.125-139 |
issn | 0270-4137 1097-0045 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5830186 |
source | Wiley-Blackwell Journals; MEDLINE |
subjects | Academies and Institutes - trends biomarkers California Congresses as Topic - trends diagnosis Early Medical Intervention - methods Early Medical Intervention - trends Humans Interprofessional Relations Male molecular imaging oligometastatic Patient Care Team - trends Prostatic Neoplasms - diagnosis Prostatic Neoplasms - therapy Research Report therapeutics |
title | Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A07%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multidisciplinary%20intervention%20of%20early,%20lethal%20metastatic%20prostate%20cancer:%20Report%20from%20the%202015%20Coffey-Holden%20Prostate%20Cancer%20Academy%20Meeting&rft.jtitle=The%20Prostate&rft.au=Miyahira,%20Andrea%20K.&rft.date=2016-02-01&rft.volume=76&rft.issue=2&rft.spage=125&rft.epage=139&rft.pages=125-139&rft.issn=0270-4137&rft.eissn=1097-0045&rft.coden=PRSTDS&rft_id=info:doi/10.1002/pros.23107&rft_dat=%3Cproquest_pubme%3E3923841411%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1757599190&rft_id=info:pmid/26477609&rfr_iscdi=true |